Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma
Phase 2 Completed
64 enrolled 10 charts
Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Phase 2 Completed
18 enrolled
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Phase 2 Completed
40 enrolled
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Phase 2 Completed
81 enrolled 9 charts
PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
Phase 2 Completed
32 enrolled 8 charts
Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
Phase 3 Completed
482 enrolled
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Phase 2 Completed
Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
Phase 3 Completed
167 enrolled
SYS-ACT
Completed
16 enrolled
Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Phase 2 Completed
17 enrolled
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
Completed
91 enrolled
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Completed
803 enrolled
Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy
Completed
40 enrolled
Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma
Completed
1,716 enrolled
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Completed
307 enrolled
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Completed
80 enrolled
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
Completed
48 enrolled
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
275 enrolled
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
Phase 3 Completed
432 enrolled 7 charts
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma
Phase 2 Completed
32 enrolled
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
Phase 1 Completed
28 enrolled
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Phase 1 Completed
16 enrolled
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Phase 2 Completed
76 enrolled
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
Phase 2 Completed
24 enrolled
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Phase 2 Completed
64 enrolled
E7070 in Treating Patients With Stage IV Melanoma
Phase 2 Completed
28 enrolled
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Phase 2 Completed
90 enrolled
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
Phase 2 Completed
77 enrolled